Illumina Inc. (NASDAQ: ILMN) today announced an expanded clinical oncology portfolio, unlocking the next new solutions to ...

During a live event, Gary J. Schiller, MD, reviewed the diagnostics and characteristics of blastic plasmacytoid dendritic cell neoplasm.

NeoGenomics will debut its PanTracer Family and unveil the Paletrra platform at ASCO 2025, advancing precision oncology ...

Cell.Ai, a precision oncology company developing advanced cell and molecular profiling platforms, announced the successful completion of a CLIA-grade analytical validation study of its OncoIncytes ...

Trends and Industry Outlook (2025) AI technologies are transforming medical diagnostic methods by advancing precision ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Bank of ...

Prostate cancer is the most common cancer affecting American men other than skin cancer and the second leading cause of male ...

A new method developed by researchers at the Nuffield Department of Medicine, University of Oxford, could soon unlock the ...

Outstanding service, teaching, scientific achievements, and other efforts were celebrated at the Jacobs School of Medicine and Biomedical Sciences 2025 Faculty and Staff Recognition Awards event.

K-Bro Linen Inc. ("K-Bro" or the "Corporation") is pleased to announce that it has filed a final short form prospectus dated May 27, 2025 (the "Final Prospectus") with the securities regulatory ...

A reference genome of the near-extinct northern white rhinoceros can indicate the quality of rhino stem cells that can ...

Download this article to learn how one cell therapy manufacturer optimized PCR-based Mycoplasma testing for in-house use, ...